American College of Radiology
- ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer.
martes, 29 de agosto de 2017
ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer. | National Guideline Clearinghouse
ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer. | National Guideline Clearinghouse
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario